Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Posard Matthew L.
Apr 29 18:14 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Miyashita Akiko Moni
Apr 29 18:10 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MATSUI CONNIE
Apr 29 18:09 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Krishnan Mahesh
Apr 29 18:04 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Henderson Jeffrey William
Apr 29 17:59 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Duncan Barbara Gayle
Apr 29 17:59 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Connaughton Bernadette
Apr 29 17:54 ET
Halozyme Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Krishnan Mahesh
Apr 25 16:17 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBarre Michael J.
Apr 17 19:25 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBarre Michael J.
Mar 26 19:40 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBarre Michael J.
Mar 13 17:26 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBarre Michael J.
Feb 28 18:54 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBarre Michael J.
Feb 27 17:18 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Snyder Mark Howard
Feb 27 17:15 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBrosse Nicole
Feb 27 17:13 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Torley Helen
Feb 27 17:08 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBarre Michael J.
Feb 20 19:04 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Snyder Mark Howard
Feb 20 18:59 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBrosse Nicole
Feb 20 18:54 ET
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Torley Helen
Feb 20 18:54 ET
No Data
No Data